Literature DB >> 10405754

Gadolinium-based contrast agents as an alternative at vena cavography in patients with renal insufficiency--early experience.

J A Kaufman1, S C Geller, H Bazari, A C Waltman.   

Abstract

The authors reviewed results of digital subtraction vena cavography with a gadolinium-based contrast agent in 14 patients with serum creatinine levels greater than or equal to 1.5 mg/dL (133 mumol/L). All cavograms were diagnostic. In 11 patients, there was no impairment of renal function. In three patients, a rise in serum creatinine level of greater than or equal to 0.5 mg/dL (44 mumol/L) was attributable to concurrent medical problems. Gadolinium-based contrast agents may be suitable for digital subtraction vena cavography in patients with renal insufficiency.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10405754     DOI: 10.1148/radiology.212.1.r99jl15280

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Cerebral 3D-Gadolinium-DSA in a Patient with Renal Insufficiency Presenting a Subarachnoid Haemorrhage.

Authors:  M Jacamon; F Bonneville; A Robert; J Ferreira; J F Bonneville
Journal:  Interv Neuroradiol       Date:  2004-10-20       Impact factor: 1.610

2.  Nephrotoxicity of gadolinium-based contrast in the setting of renal artery intervention: retrospective analysis with 10-year follow-up.

Authors:  Edwin A Takahashi; David F Kallmes; Kristin C Mara; William S Harmsen; Sanjay Misra
Journal:  Diagn Interv Radiol       Date:  2018-11       Impact factor: 2.630

3.  Gadolinium-based contrast agents: Stimulators of myeloid-induced renal fibrosis and major metabolic disruptors.

Authors:  Catherine Do; Bridget Ford; Doug Yoon Lee; Chunyan Tan; Patricia Escobar; Brent Wagner
Journal:  Toxicol Appl Pharmacol       Date:  2019-05-10       Impact factor: 4.219

4.  Gadolinium-enhanced CT angiography of the circle of Willis and neck.

Authors:  John W Henson; Raul G Nogueira; Diego J Covarrubias; R Gilberto Gonzalez; Michael H Lev
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

Review 5.  Actual clinical use of gadolinium-chelates for non-MRI applications.

Authors:  Holger M Strunk; H Schild
Journal:  Eur Radiol       Date:  2004-02-10       Impact factor: 5.315

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.